Pharmacotherapy for methamphetamine/amphetamine use disorder—a systematic review and meta‐analysis

Chan, Brian, Freeman, Michele, Kondo, Karli, Ayers, Chelsea, Montgomery, Jessica, Paynter, Robin, Kansagara, Devan·2019·Addiction
DOI 10.1111/add.14755

Cited by (160)

Items 101–160 of 160

  1. Sociodemographic and patient reported outcomes by racial and ethnicity status among participants in a randomized controlled trial for methamphetamine use disorder
    Chukwuemeka N. Okafor, Thomas James Carmody, Angela L. Stotts, Gavin B. Bart, Taryn L. Mayes, Tara Karns-Wright, Madhukar H. Trivedi, STEVEN J. SHOPTAW, Jennifer Sharpe Potter · 2024 · Drug and Alcohol Dependence Reports
  2. A synergistic effect of herb and acupuncture on the methamphetamine
    Jin Gyeom Lee, Yuchi Li, Nam Jun Kim, Han Byeol Jang, Chae Ha Yang, Hee Young Kim, Seong Shoon Yoon, Suchan Chang, Seon-Ju Jeong, Sang Chan Kim et al. · 2024 · Integrative Medicine Research
  3. Treatment and Research Needs for Pregnant Individuals With Substance Use Disorders
    Constance Guille · 2025 · American Journal of Psychiatry
  4. Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics)
    Hiroyuki Uchida, Euitae Kim, L. Fredrik Jarskog, W. Wolfgang Fleischhacker, Gary J. Remington, Jeffrey Alan Lieberman · 2023 · Springer eBooks
  5. Personalized rehabilitation of patients with psychostimulant addiction, taking into account the polymorphism of genes controlling the serotonin system and neuroplastic brain processes
    Поплевченков Константин Николаевич, Т. В. Агибалова, Michael Sergeevich Zastrozhin, Oleg Zh. Buzik · 2023 · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery)
  6. DEMOGRAPHIC PROFILE, SUBSTANCE USE TRENDS AND ASSOCIATED PSYCHOTIC DISORDERS AMONG VETERANS WITH MENTAL HEALTH CONDITIONS: A RETROSPECTIVE COHORT STUDY OF US VETERANS
    Jason Obermann, K. Divadeenam, A. Flynn, Hemant Thakur, Vikas Singh, Rishi Sharma, Thomas B. Wiegmann, V. Boinpelly, Ken Grasing, Mukut Sharma et al. · 2024 · ASEAN Journal of Psychiatry
  7. Comparative Effectiveness of Buprenorphine/Naloxone and Methadone on Methamphetamine/Amphetamine Use Among People with Opioid Use Disorder in Canada
    Jenna Langlois, Nadia S. Fairbairn, Didier Jutras‐Aswad, Bernard Le Foll, Keith Ahamad, Ron Lim, Maria Eugenia Socias · 2024 · Substance Use & Addiction Journal
  8. Theta burst stimulation (TBS) in methamphetamine use disorder: a meta-analysis and systematic review
    Gopalkumar Rakesh, Thomas G. Adams, Dylan H. Ballard, Christopher J. McLouth, Craig R. Rush · 2025 · Journal of Addictive Diseases
  9. Cocaine craving and use during pharmacotherapy trials for cocaine use disorder: A multi-trajectory analysis
    Ramin Mojtabai, Ryoko Susukida, Mehdi Farokhnia, Trang Quynh Nguyen, Lorenzo Leggio, Cecilia L. Bergeria, Kelly E. Dunn, Masoumeh Amin‐Esmaeili · 2025 · Drug and Alcohol Dependence
  10. Patterns and Determinants of Polystimulant Use Among Patients Seeking Treatment for Stimulant Use Disorders
    Éric Janssen, Mike Vuolo, Sophie Véron, Stanislas Spilka · 2025 · Substance Use & Misuse
  11. Availability of Screening for Blood-Borne Viruses, Sexually Transmitted Infections, and HIV Pre-Exposure Prophylaxis at US Substance Use Treatment Facilities Treating Stimulant Use Disorder
    Samuel R. Bunting, Nitin Vidyasagar, Jessica Wang, RAJ SHETTY, Aniruddha Hazra · 2026 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  12. It’s not all DAT: harnessing the potential of organic cation transporter 3 inhibition to selectively attenuate amphetamine reinforcement and dopamine release
    Lauren E. Honan, Briana Mason, W. Anthony Owens, Sangbin Shin, Yeon Ha Ju, Yonggong Shi, Rebecca E. Horton, Lief E. Fenno, Gregory Thomas Collins, Lynette C. Daws · 2026 · Neuropsychopharmacology
  13. Amphetamine und Crystal Meth: Epidemiologie, Symptomatik und Therapie konsumassoziierter Störungen
    Boris B. Quednow, Kenneth M. Dürsteler · 2022 · PSYCH up2date
  14. Delphi method applicability in drug foresight
    Tomi Lintonen, Karoliina Karjalainen, Sanna Rönkä, Elina Kotovirta, Solja Niemelä · 2024 · Substance Abuse Treatment Prevention and Policy
  15. Brain Stimulation and Methamphetamine in Iran: A Debate in the Most Populous Persian Gulf Country
    Omid Massah · 2020 · Iranian Rehabilitation Journal
  16. What is the best treatment of methamphetamine use disorder?
    Micheal C. Irelan, Armando Quiroz, Robert J. Marshall · 2021 · Evidence-Based Practice
  17. CHANGE IN BLOOD CHEMISTRY, PRO-INFLAMMATORY CYTOKINES, AND APOPTOTIC GENES FOLLOWING METHAMPHETAMINE USE IN EXPERIMENTAL RATS
    Zahra Goudarzi, Seyed Ebrahim Hoseini, Davood Mehrabani, Seyedeh Sara HASHEMI · 2020 · PERIÓDICO TCHÊ QUÍMICA
  18. Neurocognitive Empowerment for Addiction Treatment (NEAT): Study Protocol for a Randomized Controlled Trial
    Hamed Ekhtiari, Tara Rezapour, Brionne Sawyer, Henry Yeh, Rayus Kuplicki, Mimi Tarrasch, Martin P. Paulus, Robin L. Aupperle · 2020 · PsyArXiv (OSF Preprints)
  19. Substance Use in HIV Populations
    Thanh Thuy Truong, Elizabeth H. David · 2023
  20. Commentary on Foot et al.: Clinical considerations in addressing comorbid stimulant use in opioid use disorder
    Matisyahu Shulman, Miranda G. Greiner, Adam M. Bisaga · 2023 · Addiction
  21. Substance Use
    Lois T. Flaherty · 2023 · Springer eBooks
  22. Stimulant Use Disorder
    Michael Duerden, Marianne Klugheit, Mathew Erisman · 2024 · Springer eBooks
  23. Psychostimulants
    2024
  24. Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics)
    Hiroyuki Uchida, Euitae Kim, L. Fredrik Jarskog, W.W. Fleischhacker, Gary J. Remington, Jeffrey Alan Lieberman · 2024 · Springer eBooks
  25. Breaking the Cycle: A Scoping Review Exploring Non-Pharmacological Treatment Programs for Amphetamine-Type Stimulant Use for People in Contact with the Justice System
    Amy Lewandowski, Marc Rémond, Sharlene S. Kaye, Tazeen Majeed, Craig Cooper, Adrian John Dunlop, Elizabeth Sullivan · 2024 · Current Addiction Reports
  26. Pharmacists’ perspectives on methamphetamine use disorder in the Australian community setting
    Ali Makki, Carolyn Day, Betty Bouad Chaar · 2024 · Pharmacy Education
  27. The potential of non-psychedelic 5-HT2A agents in the treatment of substance use disorders: a narrative review of the clinical literature
    Alejandra Pulido-Saavedra, Anna Borelli, Razi Kitaneh, Mohammad Alrafayia, Laya Jalilian Khave, Melissa Christine Funaro, Marc Nicholas Potenza, Gustavo A. Angarita · 2024 · Expert Opinion on Pharmacotherapy
  28. Attitudes and Perspectives of Service Providers on Persons Who Use Stimulants in Northern and Central Mexico
    Claudia M. Rafful, Leonardo Jiménez-Rivagorza, Daniela Peralta, María Elena Medina‐Mora, Andrés Mota · 2025 · Substance Use & Addiction Journal
  29. Theta Burst Stimulation in Patients With Methamphetamine Use Disorder: A Meta-Analysis and Systematic Review
    Gopalkumar Rakesh, Thomas G. Adams, Dylan H. Ballard, Christopher J. McLouth, Craig R. Rush · 2025 · medRxiv
  30. Emerging Therapeutic Applications for Treating Methamphetamine Use Disorder
    Tuanthon Boonlue · 2025 · IntechOpen eBooks
  31. A protocol for high-dose lisdexamfetamine and contingency management, alone or in combination, for the treatment of methamphetamine use disorder: The ASCME study
    Paxton Bach, Bernard Le Foll, Sara Davidson, Alexandra de Kiewit, Hamzah Bakouni, Ginette Poulin, Monty Ghosh, Didier Jutras‐Aswad · 2025 · Contemporary Clinical Trials
  32. Stimulant Use Disorders: Focus on Cocaine and Methamphetamine
    Jean Lud Cadet · 2025 · Elsevier eBooks
  33. Substance use and HIV
    Thanh Thuy Truong · 2025
  34. References
    2025 · Wiley eBooks
  35. Amphetamine und Crystal Meth: Epidemiologie, Symptomatik und Therapie konsumassoziierter Störungen
    B. Quednow, Kenneth M. Dürsteler · 2022 · Suchttherapie
  36. Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks
    Nicky J. Mehtani, Brian T. Anderson, Irina Alexander, Peter S. Hendricks, Jennifer Mitchell, Phillip Oliver Coffin, Mallory O. Johnson · 2025 · BMJ Open
  37. Stimulants
    Ryan Graddy, Darius A. Rastegar · 2025 · Oxford University Press eBooks
  38. Comparison between a chimeric anti-methamphetamine monoclonal antibody and humanized antibodies on pharmacological effects of methamphetamine
    Michael D. Berquist, Melinda G. Gunnell, Ralph L. Henry, William Brooks Gentry, Misty W. Stevens · 2025 · Psychopharmacology
  39. Additional file 1 of Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature
    Hamel, C., Corace, K., Hersi, M., Rice, D., Willows, M., Macpherson, P., Sproule, B., Flores-Aranda, J., Garber, G., Leila Esmaeilisaraji et al. · 2020 · Figshare
  40. Additional file 1 of Neurocognitive Empowerment for Addiction Treatment (NEAT): study protocol for a randomized controlled trial
    Hamed Ekhtiari, Tara Rezapour, Brionne Sawyer, Yeh, Hung-Wen, Rayus Kuplicki, Mimi Tarrasch, Martin P. Paulus, Robin L. Aupperle · 2021 · Figshare
  41. Additional file 1 of Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999–2018
    Marwa Rawy, Gergis Abdalla, Kevin A. Look · 2024 · Figshare
  42. Additional file 2 of Neurocognitive Empowerment for Addiction Treatment (NEAT): study protocol for a randomized controlled trial
    Hamed Ekhtiari, Tara Rezapour, Brionne Sawyer, Yeh, Hung-Wen, Rayus Kuplicki, Mimi Tarrasch, Martin P. Paulus, Robin L. Aupperle · 2021 · Figshare
  43. Additional file 5 of Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature
    Hamel, C., Corace, K., Hersi, M., Rice, D., Willows, M., Macpherson, P., Sproule, B., Flores-Aranda, J., Garber, G., Leila Esmaeilisaraji et al. · 2020 · Figshare
  44. Additional file 4 of Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature
    Hamel, C., Corace, K., Hersi, M., Rice, D., Willows, M., Macpherson, P., Sproule, B., Flores-Aranda, J., Garber, G., Leila Esmaeilisaraji et al. · 2020 · Figshare
  45. Additional file 1 of Effects of resilience on impulsivity, cognition and depression during protracted withdrawal among Chinese male methamphetamine users
    He, He, Zhou, Siyao, Chenhui Peng, Wang Ran, Siyu Tong, Hong, Lan, Fangfang Cai, Wei Jin, Yile Jiang, Li, Mengjia et al. · 2022 · Figshare
  46. Additional file 2 of Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature
    Hamel, C., Corace, K., Hersi, M., Rice, D., Willows, M., P. MacPherson, Sproule, B., Flores-Aranda, J., Garber, G., Leila Esmaeilisaraji et al. · 2020 · Figshare
  47. Additional file 3 of Psychosocial and pharmacologic interventions for methamphetamine addiction: protocol for a scoping review of the literature
    Hamel, C., Corace, K., Hersi, M., Rice, D., Willows, M., Macpherson, P., Sproule, B., Flores-Aranda, J., Garber, G., Leila Esmaeilisaraji et al. · 2020 · Figshare
  48. A qualitative analysis of participant expectations and experiences of psilocybin‐assisted psychotherapy for methamphetamine use disorder
    Jonathan Brett, Toby Lea, Elizabeth Knock, Steven M. Albert, Liam S. Acheson, Krista J. Siefried, Sebastian Job · 2025 · Addiction
  49. Stimulant use disorder indicative of increased serum soluble intercellular adhesion molecule-1 concentrations with altered brain reward and interoceptive processing
    Kaiping Burrows, Breanna A. McNaughton, Angela K. Yakshin, Valerio Coussa, Rayus Kuplicki, Robin L. Aupperle, Jonathan B. Savitz, Martin P. Paulus, Jennifer Lorraine Stewart, Leandra K. Figueroa‐Hall · 2026 · Brain Behavior and Immunity
  50. Effect of aerobic exercise on relapse tendency in individuals with methamphetamine use disorder in a virtual social environment: Mediated by cue-induced craving and interoceptive sensibility
    Xiaoxia LIU, Zefan FAN · 2026 · Journal of Evidence-Based Psychotherapies
  51. Uptake and Retention on Prescribed Psychostimulants for Harm Reduction: A Canadian Cohort Study
    Paxton Bach, JinCheol Choi, Wing Yin Mok, M‐J Milloy, Kora DeBeck, Thomas H Kerr, Kanna Hayashi · 2026 · Substance Use & Addiction Journal
  52. Recruitment feasibility for deep brain stimulation compared to transcranial magnetic stimulation treatment trials for methamphetamine use disorder
    Joseph T. Sakai, Jody Tanabe, Kristen M. Raymond, Pamela David Gerecht, Hannah Gebhardt, Melina Kilen, John A. Thompson, Drew S. Kern, Steve Ojemann, Marilyn Coors et al. · 2026 · Addictive Behaviors Reports
  53. Pharmacotherapy for online behavioral addictions: a systematic review
    Jennifer J. Park, Bryan B Chen, Marc N. Potenza · 2026 · Future Science OA
  54. Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder
    Ike de la Peña, Justin Row, Wei-Xing Shi · 2026 · Expert Opinion on Pharmacotherapy
  55. Mirtazapine for Methamphetamine Use Disorder: A Randomized Double-blind Placebo-controlled Trial on Craving, Mood, and Abstinence
    Mahdis Saffari Moghaddam, Ronak Mihan, Samaneh Hosseinzadeh, Gita Sadighi · 2026 · Journal of Addiction Medicine
  56. Treating addiction with an addictive drug: the ketamine paradox revisited
    Alqassem Y. Hakami · 2026 · Frontiers in Psychiatry
  57. The Effectiveness of Cognitive Rehabilitation on Cognitive Flexibility, Working Memory, Response Inhibition, and Drug Craving in Abstinent Addicts
    Mojtaba Rajabpour, Mahnaz Zargarani, Ali Rashidy‐Pour · 2026 · Addiction and Health
  58. Effects of Crocin Supplementation on Clinical Symptoms, Cognitive Function and Psychological Status in Methamphetamine Users: A Randomized Controlled Trial
    Morteza Zamani Asadolah‐poor‐kashi, Hamid Reza Banafshe, Mehrdad Simani, Fatemeh Sadat Ghoreishi, Zahra Zanjani, Amir Ghaderi · 2026 · Jundishapur Journal of Natural Pharmaceutical Products
  59. Patient and Provider Demand for and Readiness to Adopt Medications for Stimulant Use Disorders in Real‐World Settings: Pre‐Planning Toward Accelerated Implementation
    Enya B. Vroom, Erin P. Finley, Carma Deem Bolton, Tara Karns-Wright, Jennifer Sharpe Potter · 2026 · Drug and Alcohol Review
  60. Longitudinal dynamics of the gut microbiome during methamphetamine addiction and abstinence
    Lingxiao Wang, Jiaqi Wang, Yi Zhang, Baojing Wang, Xiaomeng Sun, Yànhuá Lǐ, Jiangwei Yan, Keming Yun, Hongliang Su · 2026 · Frontiers in Microbiology